NASDAQ:TNDM Tandem Diabetes Care (TNDM) Stock Price, News & Analysis $19.98 +3.13 (+18.58%) Closing price 04:00 PM EasternExtended Trading$20.19 +0.21 (+1.05%) As of 07:58 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock About Tandem Diabetes Care Stock (NASDAQ:TNDM) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Tandem Diabetes Care alerts:Sign Up Key Stats Today's Range$18.27▼$20.3950-Day Range$16.35▼$33.5952-Week Range$15.75▼$53.69Volume4.75 million shsAverage Volume1.52 million shsMarket Capitalization$1.33 billionP/E RatioN/ADividend YieldN/APrice Target$39.81Consensus RatingModerate Buy Company OverviewTandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes technology solutions for people living with diabetes in the United States and internationally. The company's flagship product is the t:slim X2 insulin delivery system, a pump platform for managing insulin delivery and display continuous glucose monitoring sensor information directly on the pump home screen; and Tandem Mobi insulin pump, an automated insulin delivery system. It also sells single-use products, including cartridges for storing and delivering insulin, and infusion sets that connect the insulin pump to the user's body. In addition, the company offers Tandem Device Updater used to update the pump software from a personal computer; Tandem Source, a web-based data management platform, which provides a visual way to display diabetes therapy management data from the pumps, integrated CGMs, and supported blood glucose meters; and Sugarmate, a mobile app used to help people visualize diabetes therapy data. The company was formerly known as Phluid Inc. and changed its name to Tandem Diabetes Care, Inc. in January 2008. Tandem Diabetes Care, Inc. was incorporated in 2006 and is headquartered in San Diego, California.Read More… Tandem Diabetes Care Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks93rd Percentile Overall ScoreTNDM MarketRank™: Tandem Diabetes Care scored higher than 93% of companies evaluated by MarketBeat, and ranked 108th out of 916 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion4.3 / 5Analyst RatingModerate Buy Consensus RatingTandem Diabetes Care has received a consensus rating of Moderate Buy. The company's average rating score is 2.53, and is based on 9 buy ratings, 8 hold ratings, and no sell ratings.Amount of Analyst CoverageTandem Diabetes Care has been the subject of 12 research reports in the past 90 days, demonstrating strong analyst interest in this stock.Read more about Tandem Diabetes Care's stock forecast and price target. Earnings and Valuation0.6 / 5Proj. Earnings GrowthGrowing Earnings GrowthEarnings for Tandem Diabetes Care are expected to grow in the coming year, from ($1.68) to ($1.20) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Tandem Diabetes Care is -10.35, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Tandem Diabetes Care is -10.35, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioTandem Diabetes Care has a P/B Ratio of 4.15. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Short Interest4.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted9.93% of the float of Tandem Diabetes Care has been sold short.Short Interest Ratio / Days to CoverTandem Diabetes Care has a short interest ratio ("days to cover") of 3.9, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Tandem Diabetes Care has recently decreased by 12.24%, indicating that investor sentiment is improving significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldTandem Diabetes Care does not currently pay a dividend.Dividend GrowthTandem Diabetes Care does not have a long track record of dividend growth. Sustainability and ESG4.9 / 5Environmental Score-0.64 Percentage of Shares Shorted9.93% of the float of Tandem Diabetes Care has been sold short.Short Interest Ratio / Days to CoverTandem Diabetes Care has a short interest ratio ("days to cover") of 3.9, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Tandem Diabetes Care has recently decreased by 12.24%, indicating that investor sentiment is improving significantly. News and Social Media2.8 / 5News Sentiment0.99 News SentimentTandem Diabetes Care has a news sentiment score of 0.99. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.84 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 31 news articles for Tandem Diabetes Care this week, compared to 7 articles on an average week.Search InterestOnly 2 people have searched for TNDM on MarketBeat in the last 30 days. This is a decrease of -33% compared to the previous 30 days. Company Ownership1.7 / 5Insider TradingAcquiring Shares Insider Buying vs. Insider SellingIn the past three months, Tandem Diabetes Care insiders have bought more of their company's stock than they have sold. Specifically, they have bought $190,949.00 in company stock and sold $0.00 in company stock.Percentage Held by InsidersOnly 1.90% of the stock of Tandem Diabetes Care is held by insiders.Read more about Tandem Diabetes Care's insider trading history. Receive TNDM Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Tandem Diabetes Care and its competitors with MarketBeat's FREE daily newsletter. Email Address TNDM Stock News Headlines4TNDM : Tandem Diabetes Care Stock: A Deep Dive Into Analyst PerspectivesMay 1 at 1:32 PM | benzinga.comTNDM: Stifel Adjusts Price Target for Tandem Diabetes Care | TNDM Stock NewsMay 1 at 1:12 PM | gurufocus.comHere’s How to Claim Your Stake in Elon’s Private Company, xAII predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new millionaires than any tech advance in history. And for a limited time, you have the chance to claim a stake in this project, even though it’s housed inside Elon’s private company, xAI.May 1, 2025 | Brownstone Research (Ad)Tandem Diabetes (TNDM) Target Price Revised as Analysts Remain Optimistic | TNDM Stock NewsMay 1 at 7:15 AM | gurufocus.comTandem Diabetes Care highlights potential for type 2 diabetes market growth with Control-IQ+May 1 at 3:31 AM | msn.comTandem Diabetes Care Inc (TNDM) Q1 2025 Earnings Call Highlights: Record Sales and Strategic ...May 1 at 3:31 AM | finance.yahoo.comQ1 2025 Tandem Diabetes Care Inc Earnings Call TranscriptMay 1 at 1:34 AM | gurufocus.comTandem Diabetes Care, Inc. (TNDM) Q1 2025 Earnings Conference Call TranscriptApril 30 at 9:04 PM | seekingalpha.comSee More Headlines TNDM Stock Analysis - Frequently Asked Questions How have TNDM shares performed this year? Tandem Diabetes Care's stock was trading at $36.02 at the beginning of the year. Since then, TNDM stock has decreased by 44.5% and is now trading at $19.98. View the best growth stocks for 2025 here. How were Tandem Diabetes Care's earnings last quarter? Tandem Diabetes Care, Inc. (NASDAQ:TNDM) posted its quarterly earnings results on Wednesday, April, 30th. The medical device company reported ($0.67) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.60) by $0.07. The firm's revenue was up 22.3% compared to the same quarter last year. Read the conference call transcript. When did Tandem Diabetes Care's stock split? Tandem Diabetes Care's stock reverse split on the morning of Tuesday, October 10th 2017. The 1-10 reverse split was announced on Monday, October 9th 2017. The number of shares owned by shareholders was adjusted after the closing bell on Monday, October 9th 2017. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split. Who are Tandem Diabetes Care's major shareholders? Tandem Diabetes Care's top institutional shareholders include Stephens Investment Management Group LLC (2.56%), Brown Advisory Inc. (1.39%), Principal Financial Group Inc. (0.60%) and Envestnet Asset Management Inc. (0.48%). Insiders that own company stock include Kim D Blickenstaff, Dick Allen, Leigh Vosseller, Jean-Claude Kyrillos, John F Sheridan, Kathleen Mcgroddy-Goetz, Christopher J Twomey, David B Berger, Shannon Marie Hansen, Mark David Novara and Rebecca B Robertson. View institutional ownership trends. How do I buy shares of Tandem Diabetes Care? Shares of TNDM stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Tandem Diabetes Care own? Based on aggregate information from My MarketBeat watchlists, some other companies that Tandem Diabetes Care investors own include NVIDIA (NVDA), Meta Platforms (META), Advanced Micro Devices (AMD), Tesla (TSLA), PayPal (PYPL), Alibaba Group (BABA) and Netflix (NFLX). Company Calendar Last Earnings4/30/2025Today5/01/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Surgical & medical instruments Sub-IndustryMedical Equipment Current SymbolNASDAQ:TNDM CIK1438133 Webwww.tandemdiabetes.com Phone(858) 366-6900FaxN/AEmployees2,600Year Founded2006Price Target and Rating Average Stock Price Target$41.56 High Stock Price Target$75.00 Low Stock Price Target$20.00 Potential Upside/Downside+111.1%Consensus RatingModerate Buy Rating Score (0-4)2.53 Research Coverage17 Analysts Profitability EPS (Most Recent Fiscal Year)($1.46) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-222,610,000.00 Net Margins-14.84% Pretax Margin-14.42% Return on Equity-44.19% Return on Assets-11.99% Debt Debt-to-Equity Ratio1.29 Current Ratio2.90 Quick Ratio2.32 Sales & Book Value Annual Sales$940.20 million Price / Sales1.39 Cash FlowN/A Price / Cash FlowN/A Book Value$4.81 per share Price / Book4.09Miscellaneous Outstanding Shares66,563,000Free Float64,232,000Market Cap$1.31 billion OptionableOptionable Beta1.52 Social Links The Best High-Yield Dividend Stocks for 2025Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.Get This Free Report This page (NASDAQ:TNDM) was last updated on 5/1/2025 by MarketBeat.com Staff From Our PartnersHow to invest in Elon Musk’s Optimus before its launchElon Musk is set to completely take over the AI industry with Optimus… A breakthrough AI-powered robot that El...InvestorPlace | SponsoredTrump to solve American wealth loss?Is President Trump’s Executive Order 14179… A secret way to restore wealth for good citizens? If you’ve ...Paradigm Press | SponsoredTrump announcement boosts “next Bitcoin”President Trump just made his first big crypto move ... Announcing the creation of a national strategic re...Weiss Ratings | SponsoredElon’s Terrifying Warning Forces Trump To Take ActionElon Musk has avoided two major financial crises before. He pulled Tesla and SpaceX back from the brink of col...American Hartford Gold | SponsoredThe Worst Year in American Financial History?Economist Explains: The Curse on the U.S. Dollar Yes, there is a Curse on the U.S. Dollar... and it's behin...Stansberry Research | SponsoredThis Is How Empires FallThe headlines scream tariffs and export bans — but the real damage is happening in retirement portfolios. Tim ...Investors Alley | SponsoredIs he more powerful than Trump? Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredTrump and Buffett Are Quietly Leading America’s Gold RevivalThe “Buffett Indicator” Predicts Gold Set To Dominate for Next Decade Each time the Buffett Indicator has...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Tandem Diabetes Care, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Tandem Diabetes Care With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.